Published Paper Details:

INTRODUCTION : Cardiovascular diseases and otolaryngeal (ENT) cancers pose significant challenges to global health, being leading causes of morbidity and mortality. Although environmental risk factors contribute to the increasing prevalence of these two conditions, their correlation has not been adequately explored. Common risk factors, such as smoking and male gender, play a crucial role in the development of ENT cancers including laryngeal cancer and cardiovascular diseases. OBJECTIF : Examine in detail the links between cardiovascular risk factors (age, sex, smoking, diabetes, hypertension, dyslipidemia) and the characteristics of laryngeal cancers, emphasizing the importance of a systematic cardiac evaluation. METHOD : This study, involving 100 patients with laryngeal cancer, carried out in the otolaryngology and cardiology departments, aimed to evaluate the correlation between cardiovascular risk factors and laryngeal cancers. Demographic data, cardiovascular risk factors and LDLc levels were analyzed. Results indicated significant associations between chronic smoking, diabetes, hypertension, dyslipidemia and laryngeal cancers. The average LDLc level was determined. Ethical guidelines were followed, emphasizing the importance of cardiac evaluation in the management of patients with laryngeal cancer. This methodology ensures a comprehensive exploration of cardiovascular risk factors and their relevance to laryngeal cancers, highlighting the essential role of cardiac assessment in clinical care. RESULTS : The results included one hundred patients, with an average age of 64 years and a male predominance. Among these patients, 61%, 63%, 52%, and 54% were chronic smokers, hypertensive, diabetic, and had dyslipidemia, respectively. Metastatic cancers were relatively associated with LDLc levels, with respective p-values of 0.056. CONCLUSION : This study highlights the correlation between cardiovascular risk factors and laryngeal cancers, highlighting the need for cardiac evaluation in these patients. Integrated management of these risks could potentially improve clinical outcomes. Prospective studies and clinical trials are necessary to consolidate these results and refine treatment protocols. Meanwhile, integration of cardiac assessment into daily clinical practice is recommended for a more holistic approach to laryngeal cancer patients.